RE: Massive re-rate coming with full year results and new products28 May 2022 08:57
I believe MHC will deliver a great set of results on the Covid Revenue however the focus is clearly moving to new revenue streams. If we release the new products prior to results or along with them then is easily probable we could significantly rise. However any failure to deliver positive as regards new products wouldn’t go down well but this is unlikely. I personally have constantly topped up and had a few more yesterday but I’m long term so only see short term falls as a buying opportunity. I believe in the board so prepared to continue investment in MHC.